Abnormal Uterine Bleeding
Conditions
Brief summary
Comparison of the efficiency of oral Etoricoxib versus intravenous Fentanyl on post operative Pain in curettage under TIVA: A randomized controlled trial
Detailed description
Fractional Curettage is the most widely used for diagnostic and treatment abnormal uterine bleeding. The patient categorize post-operative pain as mild to moderate. Therefore, the effective analgesic added on intraoperative and post-operative is the most important factor in patient's satisfaction, patient well co-operation, shortness time of operation, decrease unpleasant symptoms and rapid recovery. However, there are many anesthetic technique that can be used to relive pain in the operation such as local anesthesia, total intravenous anesthesia, regional anesthesia or oral analgesic drugs. Intravenous Fentanyl is an short acting opioid. It has a fast onset of action within 2 minutes and short duration of action 30-60 minutes. Respiratory depression, hypotension and bradycardia are adverse effects that might delayed discharge especially in one day surgery e.g. fractional curettage. Etoricoxib is an oral COX-2 specific inhibitor which can be used to relieve the pain. The onset of analgesia can be occurred within 24 minutes which peak plasma level within 60 minutes. There are many empirical evidences to support the results of post-operative pain after used oral Etoricoxib or intravenous Fentanyl. However, there are less evidences to support efficiency of oral Etoricoxib versus intravenous Fentanyl on post-operative Pain in fractional curettage under TIVA
Interventions
PROCEDUREfractional curettage
Fractional curettage under TIVA by used oral Etoricoxib120 mg at 30 minutes before fractional curettage and then added intravenous Propofol 2 mg/kg when start the procedure or Intravenous Fentanyl 1 microgram/kg and Propofol 2 mg/kg when start the procedure
Sponsors
Department of Medical Services Ministry of Public Health of Thailand
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Women who having abnormal uterine bleeding undergoing fractional curettage under TIVA
Exclusion criteria
* Women who have opioid or NSAIDs allergy * Women who disagree to participate in this study * Women who have history of gastrointestinal bleeding or ulcer * Women who have abnormal kidney function * Women who can't understand Thai language * Women who have American Society of Anesthesiologists \[ASA\] above 2 * Women who have been used NSAIDs in 48 hours or often used NSAIDs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| post operative pain | at 60 minute after operation | Compare efficacy of oral Etoricoxib and intravenous Fentanyl for post fractional curettage pain by using a visual analog pain scale \[Score 0-10\] |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adverse effect from the drugs during and post operation | since subject receive drugs until 60 minutes after procedure | Record subject experience of the following symptoms : nausea and vomiting ,dizziness, drowsiness ,allergic reaction ,chest pain ,and gastrointestinal bleeding or gastrointestinal discomfort |
| Amount of intravenous Propofol used in the procedure | only intraoperative time | Record dose of intravenous Propofol that used in TIVA |
| The first time pain reliever was used in post operation | within 60 minutes after the procedure | Record the first time patient asked for post operative pain reliver or visual analog pain score \> 5 |
Countries
Thailand
Outcome results
None listed